Loading...
Bienvenue sur la collection HAL de l'Institut de Recherche en Cancérologie de Montpellier
Collaborations internationales
Derniers dépôts
-
Pénélope Desroys Du Roure, Laurie Lajoie, Aude Mallavialle, Lindsay Alcaraz, Hanane Mansouri, et al.. A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer. Journal for Immunotherapy of Cancer, 2024, 12 (1), pp.e007135. ⟨10.1136/jitc-2023-007135⟩. ⟨hal-04459385⟩
-
Léo Plaçais, Stéphane Dalle, Olivier Dereure, Sabiha Trabelsi, Sophie Dalac, et al.. Risk of irAEs in patients with autoimmune diseases treated by immune checkpoint inhibitors for stage III or IV melanoma: results from a matched case–control study. Annals of the Rheumatic Diseases, 2022, 81 (10), pp.1445-1452. ⟨10.1136/ard-2022-222186⟩. ⟨hal-04079755⟩